180 Life Sciences Corp. entered a Securities Purchase Agreement on July 29, 2025, to sell 160,377,358 shares of common stock at $2.65 each and issue Pre-Funded Warrants for 16,831,882 shares, expecting to raise funds for management bonuses and cryptocurrency operations. Additionally, they will offer up to $150 million in debt securities and have aligned with strategic advisors for their digital asset treasury strategy.